Business Description
AlloVir Inc
NAICS : 541714
SIC : 2834
ISIN : US0198181036
Share Class Description:
ALVR: Ordinary SharesDescription
AlloVir Inc is a late clinical-stage cell therapy company. The company focuses on developing innovative allogeneic T-cell therapies to combat viral diseases. Their proprietary VST therapy platform enables the creation of off-the-shelf VSTs, addressing the urgent medical need for treating patients with limited viral disease treatment options. With a singular focus on research, development, and commercialization, the company's platform targets 11 devastating viruses, with posoleucel being the lead candidate addressing six viruses. Operating within one segment, the company is dedicated to preventing and treating severe viral-associated diseases through off-the-shelf VST therapies.
Financial Strength
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 6.71 | |||||
| Equity-to-Asset | 0.76 | |||||
| Debt-to-Equity | 0.19 | |||||
| Debt-to-EBITDA | -0.15 | |||||
| Interest Coverage | N/A |
N/A
|
N/A
| |||
| Piotroski F-Score | 2/9 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year EBITDA Growth Rate | 13.1 | |||||
| 3-Year EPS without NRI Growth Rate | 13.9 | |||||
| 3-Year FCF Growth Rate | 19.2 | |||||
| 3-Year Book Growth Rate | -39.3 |
Momentum Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 71.85 | |||||
| 9-Day RSI | 64.32 | |||||
| 14-Day RSI | 59.6 | |||||
| 6-1 Month Momentum % | -44.09 | |||||
| 12-1 Month Momentum % | -78.15 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 6.61 | |||||
| Quick Ratio | 6.61 | |||||
| Cash Ratio | 6.48 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -22.6 | |||||
| Shareholder Yield % | -6.4 |
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| ROE % | -96.34 | |||||
| ROA % | -76.6 | |||||
| ROIC % | -461.66 | |||||
| ROC (Joel Greenblatt) % | -759.11 | |||||
| ROCE % | -82.3 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PB Ratio | 0.63 | |||||
| Price-to-Tangible-Book | 0.63 | |||||
| EV-to-EBIT | 0.37 | |||||
| EV-to-EBITDA | 0.37 | |||||
| EV-to-FCF | 0.54 | |||||
| Price-to-Net-Current-Asset-Value | 0.64 | |||||
| Price-to-Net-Cash | 0.66 | |||||
| Earnings Yield (Greenblatt) % | 270.27 | |||||
| FCF Yield % | -135.38 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:ALVR
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
AlloVir Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | |||
| EPS (TTM) ($) | -1.84 | ||
| Beta | 0.25 | ||
| Volatility % | 81.08 | ||
| 14-Day RSI | 59.6 | ||
| 14-Day ATR ($) | 0.040833 | ||
| 20-Day SMA ($) | 0.76182 | ||
| 12-1 Month Momentum % | -78.15 | ||
| 52-Week Range ($) | 0.6231 - 6.12 | ||
| Shares Outstanding (Mil) | 114.91 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 2 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
AlloVir Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
AlloVir Inc Stock Events
| Event | Date | Price($) | ||
|---|---|---|---|---|
| No Event Data | ||||
AlloVir Inc Frequently Asked Questions
What is AlloVir Inc(ALVR)'s stock price today?
The current price of ALVR is $0.80. The 52 week high of ALVR is $6.12 and 52 week low is $0.62.
When is next earnings date of AlloVir Inc(ALVR)?
The next earnings date of AlloVir Inc(ALVR) is 2024-05-03 Est..
Does AlloVir Inc(ALVR) pay dividends? If so, how much?
AlloVir Inc(ALVR) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers